Researchers track Real-World impact of new asthma drug
NCT ID NCT06566885
Summary
This study aims to gather real-world information on how patients with severe asthma in Russia feel after starting a treatment called tezepelumab. It will follow about 110 patients aged 12 and older for one year to see if their symptoms, breathing, and need for other medications improve. The study is observational, meaning it watches what happens in regular medical care without changing how patients are treated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Kaliningrad, Russia
-
Research Site
Kemerovo, Russia
-
Research Site
Krasnodar, Russia
-
Research Site
Moscow, Russia
-
Research Site
Nal'chik, Russia
-
Research Site
Nizhny Novgorod, Russia
-
Research Site
Novosibirsk, Russia
-
Research Site
Orenburg, Russia
-
Research Site
Petrozavodsk, Russia
-
Research Site
Saint Petersburg, Russia
-
Research Site
Shelehov, Russia
-
Research Site
Stavropol, Russia
-
Research Site
Tomsk, Russia
-
Research Site
Ulan-Ude, Russia
-
Research Site
Yekaterinburg, Russia
Conditions
Explore the condition pages connected to this study.